Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T12:51:10.015Z.
Calculation as of: 2026-10-06T12:51:10.015Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a08bb0e768e445b647833b1fa03ab76594e1458f06569fc43a1aa259a4caca38
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2024-08-14.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
PS RATIO AVG TTM
N/A
PS RATIO AVG 3Y
N/A
PS RATIO AVG 5Y
N/A
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$453.70M
PS Ratio
N/A
TTM Avg
70.89
3Y Avg
76.22
5Y Avg
76.22
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $478.54M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $481.33M | 1.52 | 3.28 | 9.68 | 27.67 |
| Cerus Corporation (CERS)vs › | $471.57M | 2.13 | 2.12 | 1.95 | 3.28 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.30M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $468.31M | 3.35 | 2.88 | 3.66 | 4.95 |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | 0.64 | 0.42 | 0.50 | 0.63 |
| Evolus, Inc. (EOLS)vs › | $491.93M | 1.55 | 1.38 | 2.53 | 3.18 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | N/A | 70.89 | 76.22 | 76.22 |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | 6.02 | 6.30 | 5.65 | 8.52 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | N/A | 46.72 | 25.82 | 135.95 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-05 |
| Q1 FY2026Period ended 2026-03-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $0 |
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2024-08-14 | 8.89 |
| 2024-08-13 | 8.37 |
| 2024-08-12 | 8.91 |
| 2024-08-09 | 8.39 |
| 2024-08-08 | 8.55 |
| 2024-08-07 | 8.67 |
| 2024-08-06 | 9.34 |
| 2024-08-05 | 8.69 |
| 2024-08-02 | 9.65 |
| 2024-08-01 | 10.03 |
| 2024-07-31 | 10.32 |
| 2024-07-30 | 10.90 |
| 2024-07-29 | 10.90 |
| 2024-07-26 | 10.80 |
| 2024-07-25 | 10.83 |
| 2024-07-24 | 10.84 |
| 2024-07-23 | 11.06 |
| 2024-07-22 | 11.00 |
| 2024-07-19 | 10.37 |
| 2024-07-18 | 10.82 |
| 2024-07-17 | 10.83 |
| 2024-07-16 | 11.19 |
| 2024-07-15 | 10.80 |
| 2024-07-12 | 10.69 |
| 2024-07-11 | 10.80 |
| 2024-07-10 | 10.83 |
| 2024-07-09 | 10.61 |
| 2024-07-08 | 10.75 |
| 2024-07-05 | 10.30 |
| 2024-07-03 | 10.34 |
| 2024-07-02 | 10.64 |
| 2024-07-01 | 10.80 |
| 2024-06-28 | 9.06 |
| 2024-06-27 | 9.65 |
| 2024-06-26 | 10.70 |
| 2024-06-25 | 10.25 |
| 2024-06-24 | 9.87 |
| 2024-06-21 | 9.56 |
| 2024-06-20 | 10.12 |
| 2024-06-18 | 9.80 |
| 2024-06-17 | 8.23 |
| 2024-06-14 | 8.23 |
| 2024-06-13 | 8.53 |
| 2024-06-12 | 8.57 |
| 2024-06-11 | 8.21 |
| 2024-06-10 | 9.22 |
| 2024-06-07 | 8.39 |
| 2024-06-06 | 8.29 |
| 2024-06-05 | 8.28 |
| 2024-06-04 | 8.09 |
| 2024-06-03 | 8.09 |
| 2024-05-31 | 7.88 |
| 2024-05-30 | 7.72 |
| 2024-05-29 | 7.90 |
| 2024-05-28 | 7.56 |
| 2024-05-24 | 8.11 |
| 2024-05-23 | 8.29 |
| 2024-05-22 | 8.16 |
| 2024-05-21 | 8.23 |
| 2024-05-20 | 8.08 |
| 2024-05-17 | 7.97 |
| 2024-05-16 | 7.52 |
| 2024-05-15 | 7.70 |
| 2024-05-14 | 7.77 |
| 2024-05-13 | 7.78 |
| 2024-05-10 | 7.95 |
| 2024-05-09 | 8.05 |
| 2024-05-08 | 7.89 |
| 2024-05-07 | 7.44 |
| 2024-05-06 | 7.45 |
| 2024-05-03 | 7.08 |
| 2024-05-02 | 7.49 |
| 2024-05-01 | 7.77 |
| 2024-04-30 | 7.84 |
| 2024-04-29 | 8.04 |
| 2024-04-26 | 7.90 |
| 2024-04-25 | 8.04 |
| 2024-04-24 | 8.01 |
| 2024-04-23 | 8.00 |
| 2024-04-22 | 7.91 |
| 2024-04-19 | 7.75 |
| 2024-04-18 | 7.78 |
| 2024-04-17 | 7.74 |
| 2024-04-16 | 7.82 |
| 2024-04-15 | 7.34 |
| 2024-04-12 | 7.79 |
| 2024-04-11 | 8.00 |
| 2024-04-10 | 7.41 |
| 2024-04-09 | 7.64 |
| 2024-04-08 | 7.66 |
| 2024-04-05 | 7.74 |
